B. Braun Medical Inc. recalled 47,148 containers of Sodium Chloride Injection on August 18, 2025. The recall follows the discovery of particulate matter in the product. Consumers and healthcare providers must stop using the injection immediately.
Presence of Particulate Matter.
Consumers and healthcare providers should stop using this product immediately. Contact B BRAUN MEDICAL INC or your healthcare provider for guidance. Notification method: Letter
The recall affects 0.9% Sodium Chloride Injection USP in 1000 mL containers, labeled with Lot #: V3K770 and an expiration date of January 31, 2026. The product is available by prescription only and was distributed nationwide in the U.S.
The presence of particulate matter in the Sodium Chloride Injection poses a significant health risk. Particulates can lead to serious complications when injected.
No specific injury or incident counts have been reported associated with this recall. However, the potential for serious adverse effects exists.
Stop using the recalled Sodium Chloride Injection immediately. Consumers should contact B. Braun Medical or their healthcare provider for further guidance.
For more information, contact B. Braun Medical Inc. at the number provided in the recall notification letter.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.